Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Topper James N
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Parikh Asit
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director COLA MICHAEL F
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director FIELDS HEIDI
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director KARBE FRANK
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Stenhouse Mark
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Socks David A
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Henderson Molly
Phathom Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Takeda Pharmaceutical Company Limited(4.8%)
Phathom Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Takeda Pharmaceutical Company Limited(5.4%)
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Curran Terrie
Phathom Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Carlyle Group Inc.(6.1%),Carlyle Holdings I GP Inc.(6.1%), etc.
Phathom Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invesco Ltd.(5.5%)
Phathom Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-10% Owner Medicxi Ventures Management (Jersey) Ltd
Phathom Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Medicxi Ventures Management (Jersey) Limited(13.0%),Medicxi Growth I GP Limited(6.6%), etc.
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner TAKEDA PHARMACEUTICAL CO LTD
Phathom Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Takeda Pharmaceutical Company Limited(6.6%)
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Nabulsi Azmi
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Curran Terrie
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Henderson Molly
No Data